Research Use Only. This product is intended as a research chemical only. Not for human or animal use.

Weight Loss

Retatrutide

>99% HPLC

Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. High concentration for extended protocols.

Retatrutide 20mg

Batch RET22-34

Avg. Purity

99.64%

Avg. Mass

22.18 mg

Result Date

February 23, 2026

Date Added

March 6, 2026

Verified Report

Reviews for Retatrutide

Loading reviews...

AOD-9604 is a modified fragment of human growth hormone (hGH) comprising amino acids 177-191. It has...

Fragment 176-191 is a modified fragment of human growth hormone specifically targeting fat metabolis...

Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Standard...

Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. It repre...